Yuxintong

Yuxintong is a Traditional Chinese Medicine (TCM) formulation developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences. It is primarily indicated for the treatment of stable coronary artery disease, cardiac insufficiency, and chronic heart failure. The drug is classified under the Yiqi Huoxue therapeutic principle, which focuses on supplementing vital energy (Qi) and promoting blood circulation to resolve stasis. Clinical evaluation, including multicenter randomized controlled trials, has focused on its ability to improve cardiopulmonary exercise tolerance and overall cardiac function in patients with heart disease. The formulation typically consists of several herbal components known for their cardioprotective and vasodilatory properties, including Astragalus and Salvia miltiorrhiza.

Brand names

Yuxintong

Other names

Yiqi Huoxue HerbsYuxintong CapsulesYuxintong Granules